You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Information found below reflects the current FDA product labeling. Please note that other studies may be ongoing.
What are the common adverse events with Mounjaro® (tirzepatide) in adults?
Have there been any postmarketing adverse reactions reported with Mounjaro® (tirzepatide) use?
What are the potential drug interactions with Mounjaro® (tirzepatide) and oral medications?
What are the potential drug interactions with insulin or insulin secretagogues?